4D Molecular Therapeutics Inc (FDMT) Stock Price, Quote & News

Company Profile

4D Molecular Therapeutics, Inc., a late-stage biotechnology company, engages in the development of adeno-associated virus vectors from its proprietary synthetic vector discovery platform, Therapeutic Vector Evolution in the Netherlands and the United States. Its lead product candidate is 4D-150 for the treatment of retinal vascular diseases by providing multi-year sustained production of anti-VEGF from the retina with intravitreal injection, as well as for treating wet age-related macular degene...

Industry: Biotechnology

Sector: Healthcare

Phone: 510 505 2680

Website: www.4dmoleculartherapeutics.com

Address:

5858 Horton Street, Suite 455, Emeryville, United States

Mrwealthtrader Jun. 17 at 8:36 PM

$FDMT The decline over the past week is due to disappointing earnings, downward revisions of estimates, combined with high sector volatility and a lack of positive news flow.

0 · Reply

Emremumcu01 Jun. 17 at 4:37 PM

$FDMT strange 1 week , any thoughts anyone ?

0 · Reply

BioTechHealthX Jun. 15 at 8:17 PM

$FDMT 4D Molecular is taking aim at massive markets like AMD & cystic fibrosis with long-lasting gene therapies. Learn more about this stock here! https://biotechhealthx.com/biotech-news/4d-molecular-therapeutics-fdmt-could-be-the-next-5-billion-gene-therapy-titan/

0 · Reply

Emremumcu01 Jun. 13 at 1:44 PM

$FDMT hoping for a 4.80 close

0 · Reply

Emremumcu01 Jun. 11 at 6:50 PM

$FDMT someone tell me what went wrong , we was on the path to glory

1 · Reply

_www_larval_com_ Jun. 10 at 7:02 PM

$FDMT just dropped -3% lower to -5% (~1Mv) a moment ago, 06/20 options, follow for more volatility.

0 · Reply

Bagholder6939292929929 Jun. 10 at 5:12 PM

$FDMT

1 · Reply

ReturnOfEsquire Jun. 10 at 3:54 PM

$FDMT That action was FAF.

0 · Reply

Emremumcu01 Jun. 10 at 2:56 PM

$FDMT there was the pump , and here comes the dump……….

0 · Reply

ReturnOfEsquire Jun. 10 at 2:27 PM

$FDMT Something is up. 300K volume in an hour is way above normal.

1 · Reply

4DMT to Participate in Upcoming Investor Conferences

May 16, 2025, 4:05 PM EDT - 4 weeks ago

4DMT Announces New Employment Inducement Grants

May 8, 2025, 4:05 PM EDT - 5 weeks ago

4DMT Reports First Quarter 2025 Financial Results, Operational Highlights and Expected Upcoming Milestones

May 1, 2025, 8:00 AM EDT - 6 weeks ago

4DMT Announces RMAT Designation Granted by FDA for 4D-150 for DME

Mar 10, 2025, 8:00 AM EDT - 3 months ago

4DMT Announces First Patients Enrolled in 4FRONT-1 Phase 3 Clinical Trial Evaluating 4D-150 in Wet AMD

Feb 28, 2025, 4:05 PM EST - 3 months ago

4DMT Reports Full Year 2024 Financial Results, Operational Highlights and Expected Upcoming Milestones

Feb 18, 2025, 2:33 PM EST - 4 months ago

4D Molecular Therapeutics: A Smart Bet On Long-Term VEGF Suppression

Feb 10, 2025, 10:26 AM EST - 4 months ago

Eye Disease Focused 4D Molecular Therapeutics Lays Out 52-Week Results From Wet AMD Study

Feb 8, 2025, 2:30 PM EST - 4 months ago

4DMT Presents Positive 52-Week Results from Phase 2b Cohort of PRISM Wet AMD Study and Long-term Durability Data Supporting 4D-150 4FRONT Global Registration Program

Nov 13, 2024, 4:05 PM EST - 7 months ago

4DMT Reports Third Quarter 2024 Financial Results, Operational Highlights and Expected Upcoming Milestones

Nov 4, 2024, 11:00 AM EST - 8 months ago

4D Molecular Therapeutics Inc Is Being Investigated For Securities Fraud And The Schall Law Firm Encourages Investor Participation

Nov 2, 2024, 11:00 AM EDT - 8 months ago

4D Molecular Therapeutics Inc Is Being Investigated For Securities Fraud And The Schall Law Firm Urges Affected Investors To Reach Out

Oct 30, 2024, 11:00 AM EDT - 8 months ago

4D Molecular Therapeutics Inc Is Being Investigated For Securities Fraud And The Schall Law Firm Urges Impacted Investors To Reach Out

Oct 28, 2024, 11:00 AM EDT - 8 months ago

4D Molecular Therapeutics Inc Is Being Investigated For Securities Fraud And The Schall Law Firm Urges Affected Investors To Take Part

Oct 18, 2024, 11:00 AM EDT - 8 months ago

The Schall Law Firm Encourages Investors To Help Investigate 4D Molecular Therapeutics Inc For Possible Securities Fraud

Oct 16, 2024, 11:00 AM EDT - 8 months ago

The Schall Law Firm Urges Investor Participation In An Investigation Into 4D Molecular Therapeutics Inc For Securities Fraud

Oct 14, 2024, 11:00 AM EDT - 8 months ago

The Schall Law Firm Urges Investors To Help Investigate Whether 4D Molecular Therapeutics Inc Committed Securities Fraud

Oct 12, 2024, 11:00 AM EDT - 8 months ago

4D Molecular Therapeutics Inc Is Being Investigated For Possible Securities Fraud And The Schall Law Firm Urges Impacted Investors To Reach Out

Oct 10, 2024, 11:00 AM EDT - 8 months ago

4D Molecular Therapeutics Inc Is Being Investigated For Possible Securities Fraud And The Schall Law Firm Urges Investor Participation

Oct 8, 2024, 11:00 AM EDT - 9 months ago

4D Molecular Therapeutics Inc Is Being Investigated For Possible Securities Fraud And The Schall Law Firm Urges Affected Investors To Reach Out

Oct 6, 2024, 11:00 AM EDT - 9 months ago

4D Molecular Therapeutics, Inc. Is Being Investigated For Possible Securities Fraud And The Schall Law Firm Urges Affected Investors To Reach Out

Oct 4, 2024, 12:35 PM EDT - 9 months ago

4D Molecular Therapeutics: Market Expects Wet AMD Gene Therapy Failure - I'm Not So Sure

Oct 4, 2024, 11:00 AM EDT - 9 months ago

4D Molecular Therapeutics, Inc. Is Being Investigated For Possible Securities Fraud And The Schall Law Firm Urges Impacted Investors To Reach Out

$Shareholders Are Encouraged To Join The Schall Law Firm's Inquiry Into 4D Molecular Therapeutics Inc For Securities Related Infractions$

Oct 3, 2024, 11:00 AM EDT - 9 months ago

Shareholders Are Encouraged To Join The Schall Law Firm's Inquiry Into 4D Molecular Therapeutics Inc For Securities Related Infractions

Sep 30, 2024, 11:00 AM EDT - 9 months ago

4D Molecular Therapeutics, Inc. Is Being Investigated For Possible Securities Fraud And The Schall Law Firm Invites Affected Investors To Reach Out

Sep 27, 2024, 11:00 AM EDT - 9 months ago

Shareholders Are Urged To Take Part In The Schall Law Firm's Inquiry Into 4D Molecular Therapeutics Inc For Violating Securities Laws

Sep 26, 2024, 11:00 AM EDT - 9 months ago

4D Molecular Therapeutics, Inc. Is Being Investigated For Securities Fraud And The Schall Law Firm Invites Affected Investors To Join

Sep 24, 2024, 11:00 AM EDT - 9 months ago

4D Molecular Therapeutics, Inc. Is Being Investigated For Securities Fraud And Investors Are Urged To Assist The Schall Law Firm

$The Schall Law Firm Invites Shareholder Participation In An Inquiry Into 4D Molecular Therapeutics Inc For Securities Related Infractions$

Sep 23, 2024, 11:00 AM EDT - 9 months ago

The Schall Law Firm Invites Shareholder Participation In An Inquiry Into 4D Molecular Therapeutics Inc For Securities Related Infractions

Sep 23, 2024, 8:00 AM EDT - 9 months ago

4DMT Announces Presentation at the 2024 North American Cystic Fibrosis Conference

Sep 22, 2024, 11:00 AM EDT - 9 months ago

4D Molecular Therapeutics, Inc. Is Being Looked Into For Securities Fraud And Investors With Losses Should Contact The Schall Law Firm

Sep 20, 2024, 11:00 AM EDT - 9 months ago

4D Molecular Therapeutics, Inc. May Have Engaged In Securities Fraud And The Schall Law Firm Urges Investors To Join An Inquiry

Sep 18, 2024, 4:05 PM EDT - 9 months ago

4DMT Highlights Robust and Durable Clinical Activity for 4D-150 and Design of 4FRONT Phase 3 Program at 4D-150 Wet AMD Development Day

Sep 18, 2024, 11:00 AM EDT - 9 months ago

4D Molecular Therapeutics, Inc. May Have Engaged In Securities Fraud And Investors Are Urged To Join The Schall Law Firm's Inquiry

Sep 17, 2024, 11:00 AM EDT - 9 months ago

The Schall Law Firm Is Looking Into 4D Molecular Therapeutics Inc For Violating Securities Laws And Affected Shareholders Should Reach Out

Sep 17, 2024, 8:00 AM EDT - 9 months ago

Kaskela Law LLC Announces Stockholder Investigation of 4D Molecular Therapeutics, Inc. (NASDAQ: FDMT) and Encourages Investors to Contact the Firm

Sep 16, 2024, 11:00 AM EDT - 9 months ago

Investors Are Invited By The Schall Law Firm To Join An Inquiry Into 4D Molecular Therapeutics, Inc.'s Possible Securities Fraud

Mrwealthtrader Jun. 17 at 8:36 PM

$FDMT The decline over the past week is due to disappointing earnings, downward revisions of estimates, combined with high sector volatility and a lack of positive news flow.

0 · Reply

Emremumcu01 Jun. 17 at 4:37 PM

$FDMT strange 1 week , any thoughts anyone ?

0 · Reply

BioTechHealthX Jun. 15 at 8:17 PM

0 · Reply

Emremumcu01 Jun. 13 at 1:44 PM

$FDMT hoping for a 4.80 close

0 · Reply

Emremumcu01 Jun. 11 at 6:50 PM

$FDMT someone tell me what went wrong , we was on the path to glory

1 · Reply

_www_larval_com_ Jun. 10 at 7:02 PM

$FDMT just dropped -3% lower to -5% (~1Mv) a moment ago, 06/20 options, follow for more volatility.

0 · Reply

Bagholder6939292929929 Jun. 10 at 5:12 PM

$FDMT

1 · Reply

ReturnOfEsquire Jun. 10 at 3:54 PM

$FDMT That action was FAF.

0 · Reply

Emremumcu01 Jun. 10 at 2:56 PM

$FDMT there was the pump , and here comes the dump……….

0 · Reply

ReturnOfEsquire Jun. 10 at 2:27 PM

$FDMT Something is up. 300K volume in an hour is way above normal.

1 · Reply

jewell69 Jun. 10 at 1:00 AM

$EWA Australia b Monday 6/9 26.50 close 26.55 1st time trade. TY WSJ weekend podcast 6/7/25 new topic: Fri 6/6 Robert Sec_en CNBC RECC $JEF it is part of $IYF unable 2 buy jef 6/6 at 50.80 6/9 close 53.65 up up $FDMT we dont own it; 4.79 6/9 close up 10.11% today

0 · Reply

jewell69 Jun. 9 at 5:19 PM

$FDMT UP 5% TODAY. DONT UNDERSTAND; NO NEWS 1/13/25 sALVEEN Richter: BUY, y soooo long ago ? pt of 72. 72, really ? gena wang; 5/8/25 buy pt of 38; 38, really ? bad day 2 buy. better not even chase it.

0 · Reply

Emremumcu01 Jun. 9 at 5:18 PM

$FDMT shorts will be closing positions we could see further growth

0 · Reply

Mrwealthtrader Jun. 9 at 3:34 PM

$FDMT Phase 3 program for wet AMD: The first patients have already been enrolled in the global phase 3 study 4FRONT‑1. A second study (4FRONT‑2) is expected to begin in Q3 2025, with results anticipated in the second half of 2027.

1 · Reply

ReturnOfEsquire Jun. 9 at 3:03 PM

$FDMT What's the new resistance? 3.90 took forever.

1 · Reply

ReturnOfEsquire Jun. 9 at 2:29 PM

$FDMT Only down 33% now and with my swings the past year more like 15%.

1 · Reply

ReturnOfEsquire Jun. 9 at 2:26 PM

$FDMT Massive volume today.

0 · Reply

ReturnOfEsquire Jun. 9 at 2:25 PM

$FDMT I've been burned by a lot of biotechs. Here are my thoughts. This company does not pump and issue BS PRs like every other pre-commercial biotech I've seen. When they said they are working on partnerships and should have an update soon, perhaps that meant more than they led on? This is a massive move following the Jeffries conference. There has to be something here.

0 · Reply

Mrwealthtrader Jun. 9 at 2:02 PM

$FDMT 🌡#hotzone

0 · Reply

ReturnOfEsquire Jun. 8 at 3:55 PM

$FDMT Looking forward to tomorrow. This pig is clearly reversing but at a snail's pace. I'd like to see 5s this week.

2 · Reply

ReturnOfEsquire Jun. 6 at 8:06 PM

$FDMT I don’t think this jump and the timing of the Jeffries conference are a coincidence.

1 · Reply

History101 Jun. 6 at 7:48 PM

$FDMT diggin the 1mo chart!! GLTALs!!

0 · Reply

Market Cap	202.44M
Revenue (ttm)	40,000.00
Net Income (ttm)	-160.87M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-402,175.00%
Debt to Equity Ratio	0.00

Volume	259,900
Avg Vol	551,862
Day's Range	N/A - N/A
Shares Out	46.33M
Stochastic %K	46%
Beta	2.84
Analysts	Strong Sell
Price Target	$27.70